Lin Xiaofang
Associate Professor
Molecular Chemistry and Cell Biology
China Medical University
Taiwan
Biography
Using gain-of-function and loss-of-function approaches, Dr. Yet has made major contributions to the understanding of the cytoprotective function of heme oxygenase-1 in cardiovascular system. Dr. Yet’s laboratory was the first to demonstrate the in vivo function of cysteine-rich protein 2, an arterial smooth muscle cell protein, in vascular disease using genetically modified mice. Dr. Yet serves as a reviewer for several major scientific journals. Dr. Yet’s research projects are currently funded by a NHRI intramural grant and grants from National Science Council.
Research Interest
Cardiovascular Biology, Transcriptional Regulation, Oxidative Stress, Cytoprotection
Publications
-
Wu HW, Hsiao YH, Chen CC, Yet SF, Hsu CH. A PDMS-based microfluidic hanging drop chip for embryoid body formation. Molecules. 2016;21(7):882.
-
Lee GL, Wu JY, Tsai CS, Lin CY, Tsai YT, Lin CS, Wang YF, Yet SF, Hsu YJ, Kuo CC. TLR4-activated MAPK-IL-6 Axis regulates vascular smooth muscle cell function. Int J Mol Sci. 2016;17:1394.
-
Ho YC, Wu ML, Gung PY, Chen CH, Kuo CC, Yet SF*. Heme oxygenase-1 deficiency exacerbates angiotensin II-induced aortic aneurysm in mice. Oncotarget (Pathology). 2016;7(42):67760-76.
